Loss of heterozygosity for chromosome 22 (LOH 22) occurs in gliomas of all malignancy grades. Neurofibromatosis type 2 (NF2) patients are at increased risk of developing a glioma. However, the NF2 gene in 22q12.2 is not involved in glioma tumorigenesis. To detect additional regions on chromosome 22
Simultaneous Demonstration of glia- and glioma-associated antigens in human astrocytomas
โ Scribed by T. Bilzer; B. Martin; D. Stavrou; E. Keiditsch
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- French
- Weight
- 387 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
โฆ Synopsis
Glial fibrillary acidic protein (GFAP) and glioma-associated antigens (GAA) defined by monoclonal antibodies (MAbs) were demonstrated simultaneously in human astrocytoma tissue. GFAP was stained by PAP-method, GAA were visualized by avidin-biotin-technique using alcaline phosphatase. In primary and secondary tumors as well as in tissue culture heterogeneity of GFAP-and GAA-expression is obvious. GFAP i s mostly restricted to cell processes and less marked in the perinuclear space. Depending on the individual antibody, MAbs-positive material is located either in the tumor cell plasma or on cell surface membranes (MUC 2-63). There is remarkable expression of GAA in cell clusters which fail t o express GFAP. A t higher magnification, 3 types of cellular reactivity are detectable: (a) cells which react only with anti-GFAP, (b) cells which react only with anti-GAA and (c) cells which express both, GFAP and GAA, especially those of protoplasmic astrocyte type. These cells also occur in subcutaneous tumor grafts, and may thus represent not only a reactive event, but be part of tumor cell populations.
๐ SIMILAR VOLUMES
The authors are grateful to Dr. Henry Burger, of Melbourne, .4ustralia, for his helpful assistance in the preparation of the manuscript and his advice. 'They are also grateful for the technical assistance of Miss Simone Gaspard, Mrs. llalou Debruche, and hlrs. Yvonne Vrindts. They are also very grat
The study of tumor immunology has led to many innovative therapeutic strategies for the treatment of melanoma. The strategies are primarily dependent on melanoma-associated antigen peptide vaccination or T-cell-based therapy. These immunotherapies are totally reliant on proper copresentation of huma